Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

Phase 2 Completed 32 enrolled Assistance Publique - Hôpitaux de Paris

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether inhaled Budesonide/formoterol is effective in the treatment of bronchiolitis obliterans after allogeneic stem cell transplantation.

Timeline

Start: 2008-06
Primary completion: 2012-07
Completion: 2012-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Budesonide/formoterol	Unknown	800 ug	Inhaled

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

Summary

Timeline

Drugs

Indications